Follow the 피플바이오 stock price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 피플바이오 has published 40 insider filings. Market capitalisation: €13.9bn. The latest transaction was reported on 3 July 2026 (Other). Among the most active insiders: 강성민. Every trade is openly available.
40
Insider Decl.
n/a
Thresholds
n/a
18 ops.
Buy Volume
n/a
4 ops.
Sell Volume
5Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
PeopleBio is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative solutions for the diagnosis and treatment of diseases.